News Express: UM inaugurates UM-TIB Joint Laboratory for Synthetic Biology and Chinese Medicine
新聞快訊：中醫藥合成生物學聯合實驗室於澳大揭牌
揭牌儀式
The plaque unveiling ceremony
中醫藥合成生物學聯合實驗室於澳大揭牌
澳門大學中華醫藥研究院、中藥質量研究國家重點實驗室與中國科學院天津工業生物技術研究所今（11）日在澳大舉行“澳門中醫藥合成生物學論壇”以及“中醫藥合成生物學聯合實驗室”合作協議簽署和揭牌儀式，以推動中醫藥與合成生物學的交叉融合，探索中醫藥現代化與國際化發展的新路徑。
論壇開幕式上，澳大校長宋永華表示，中醫藥是中華民族的瑰寶，而合成生物學作為新興學科，為中醫藥的現代化提供了全新的技術手段；澳大希望通過是次論壇，進一步加強澳門與內地科研機構的合作，推動中醫藥合成生物學領域的創新發展。
中國科學院天津工業生物技術研究所所長向華在致辭中指出，合成生物學在生物製造、藥物研發等領域具有廣闊的應用前景，與中醫藥的結合將為傳統醫藥的現代化提供重要支撐。他期待通過雙方緊密合作，共同推動中醫藥合成生物學的研究與產業化發展。
隨後，澳門大學與中國科學院天津工業生物技術研究所簽署“中醫藥合成生物學聯合實驗室”合作協議及進行揭牌儀式。該聯合實驗室的成立標誌著雙方在中醫藥合成生物學領域的合作邁入新階段，未來將聚焦中醫藥資源的合成生物學研究、新藥開發及產業化應用。
論壇還舉辦了以“澳門發展中藥合成生物學與生物製造的現狀、機遇與挑戰”為主題的圓桌會議。一眾來自學術界、產業界和政府部門的專家學者共同探討通過強強合作及充分發揮澳門“一國兩制”優勢，加速澳門中醫藥合成生物學研究與中藥生物製造產業化的發展前景。論壇還邀請了中國科學院天津工業生物研究所研究員和澳門大學中華醫藥研究院教授作主題報告，分享中醫藥合成生物學領域的最新研究成果與技術進展，探討合成生物學技術在中醫藥資源開發中的潛力，以及介紹合成生物學在中藥活性成分研究中的最新進展。
是次論壇的舉辦及聯合實驗室的設立，為澳門在中醫藥合成生物學與生物製造領域提供了具有深遠影響的學術交流與合作平台。未來，澳門大學將繼續攜手中國科學院天津工業生物技術研究所，進一步深化合作，共同推進中醫藥合成生物學的研究成果落地和產業化發展，為推動中醫藥的現代化與國際化注入新的活力。
出席論壇開幕式的嘉賓還有澳門特區政府衛生局局長羅奕龍、藥物監督管理局副局長李世恩、經濟及科技發展局代副局長陳祖榮、科學技術發展基金行政委員會委員葉桂林等。
欲瀏覽官網版可登入以下連結:
https://www.um.edu.mo/zh-hant/news-and-press-releases/press-release/detail/60526/
UM inaugurates UM-TIB Joint Laboratory for Synthetic Biology and Chinese Medicine
The Institute of Chinese Medical Sciences (ICMS) and the State Key Laboratory of Quality Research in Chinese Medicine of the University of Macau (UM) and the Tianjin Institute of Industrial Biotechnology (TIB) of the Chinese Academy of Sciences jointly held the Macao Forum on Synthetic Biology and Traditional Chinese Medicine and the agreement signing and plaque unveiling ceremony for the UM-TIB Joint Laboratory for Synthetic Biology today (11 March). The event aimed to promote the interdisciplinary integration of Chinese medicine and synthetic biology, and explore new pathways for the modernisation and internationalisation of Chinese medicine.
Speaking at the opening ceremony of the forum, UM Rector Yonghua Song said that synthetic biology, as an emerging discipline, provides new technological means for the modernisation of Chinese medicine. He expressed hope that the forum would further strengthen cooperation between Macao and research institutes in mainland China, and drive innovative development in the field of synthetic biology for Chinese medicine.
In his speech, TIB Director-General Xiang Hua highlighted the vast application prospects of synthetic biology in fields such as biomanufacturing and drug research and development. He looks forward to close cooperation between the two parties to advance the research and industrialisation of synthetic biology for Chinese medicine.
Following the speeches, representatives of UM and TIB signed an agreement and unveiled the plaque for the UM-TIB Joint Laboratory for Synthetic Biology and Chinese Medicine. The joint laboratory will focus on synthetic biology research for Chinese medicine, new drug development, and industrial applications.
The forum also featured a roundtable discussion on ‘The Current Status, Opportunities, and Challenges of Developing Synthetic Biology and Biomanufacturing for Chinese Medicine in Macao’ and presentations by professors from ICMS and TIB. It brought together experts and scholars from academia, industry representatives, and government officials.
To read the news on UM’s official website, please visit the following link:
https://www.um.edu.mo/news-and-press-releases/press-release/detail/60526/